There is concern internationally that many older people are using an inappropriate number of medicines, and that complex combinations of medicines may cause more harm than good. This article discusses how person-centred medicines optimisation for older people can be conducted in clinical practice, including the process of deprescribing. The evidence supports that if clinicians actively include people in decision making, it leads to better outcomes. We share techniques, frameworks, and tools that can be used to deprescribe safely whilst placing the person’s views, values, and beliefs about their medicines at the heart of any deprescribing discussions. This includes the person-centred approach to deprescribing (seven steps), which incorporates the identification of the person’s priorities and the clinician’s priorities in relation to treatment with medication and promotes shared decision making, agreed goals, good communication, and follow up. The authors believe that delivering deprescribing consultations in this manner is effective, as the person is integral to the deprescribing decision-making process, and we illustrate how this approach can be applied in real-life case studies.
T his article has been written from a pharmacist's perspective, but the principles are applicable to any healthcare professional undertaking a medication consultation. Prior to COVID-19, consultations for older people living with frailty were routinely delivered 'face to face' in a home setting or outpatient clinic. Health and social care professionals moved between locations, guided by local pathways of care. This became the accepted practice for delivery of care, where the benefit of seeing the person face to face far outweighed the risks. The global COVID-19 pandemic has provided us with a unique opportunity to stop and evaluate our methods when delivering care in all settings. There has been a seismic shift, where the immediate risk of acute harm from face-to-face visits for the older or vulnerable patient can greatly outweigh the benefits. This has necessitated creative thinking and the need to re-engineer customary practices, but it has also given us a golden opportunity to evaluate the rationale for our previous practice. We believe that there has been an ingrained bias towards face-to-face consultations as the preferred mode of delivery, causing us to unconsciously dismiss alternative ways to deliver meaningful consultations. Patients and clinicians alike have undergone a revolution in their beliefs when undertaking consultations. Remote consultation-by phone and, increasingly, using video-are the 'new normal' and are providing effective care for the majority of people able to use these services. 1 However, there is a paucity of information about the use of remote consultation for medication review. This is not a 'one size fits all'. People with physical, mental and cognitive challenges, such as older people living with frailty
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.